Applied Genetic (AGTC)

NASDAQ
3.88
+0.21(+5.72%)
After Hours
3.89
+0.01(+0.26%)
- Real-time Data
  • Volume:
    986,037
  • Bid/Ask:
    3.76/3.88
  • Day's Range:
    3.70 - 3.90

AGTC Overview

Prev. Close
3.67
Day's Range
3.7 - 3.9
Revenue
-
Open
3.76
52 wk Range
3.53 - 9.6
EPS
-2.26
Volume
986,037
Market Cap
165.51M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
2,446,319
P/E Ratio
-
Beta
2.22
1-Year Change
-5.37%
Shares Outstanding
42,657,878
Next Earnings Date
Sep 13, 2021
What is your sentiment on Applied Genetic?
or
Market is currently closed. Voting is open during market hours.

Applied Genetic News

Applied Genetic Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell

Applied Genetic Company Profile

Applied Genetic Company Profile

Employees
83

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic therapies for patients suffering from rare and debilitating diseases. Its focus is in the field of ophthalmology where it has active clinical programs in X-linked retinitis pigmentosa (XLRP), achromatopsia (ACHM), and optogenetics. The Company has approximately one preclinical program in otology and three preclinical programs targeting central nervous system disorders (CN), including adrenoleukodystrophy (ALD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company's optogenetics program is being developed in collaboration with Bionic Sight, LLC and its otology program is being developed in collaboration with Otonomy, Inc. In addition to its product pipeline, the Company has also developed broad technological and manufacturing capabilities in synthetic promoter development and optimization.

Read More
  • Interesting price action on AGTC today. Hmmm? Volume about avg. per 10 day.
    0
    • Great new are coming!
      1
      • Have you got any?
        0
      • A lot
        0
    • You guys ready for May 3rd & 6th ? Cant wait 🔥🔥🔥🔥
      0
      • due to departure of chief scientific officer, they have to revise their target price, what they have announced previously 16 USD not reachable.
        0
        • Hold on and be patients.Future is AGTC
          0
          • if managment will not do anything, soon this stock shall be around 1 dollar.
            2
            • Incredible buying opportunity today for those who know what’s coming
              0
              • now i guess nobody belivies to this company
                2
                • What happens?
                  0
              • why do you guys think this is going to explode? I'd be interested in investing
                0
                • Check their website and future events, we will be hearing good news in the near future
                  0
              • Its going to be HUGE
                1
                • High target of 35 and low of 8
                  0
                  • 17 my friend is the low
                    1
                • https://marketingsentinel.com/2021/03/15/applied-genetic-technologies-corporation-nasdaqagtc-the-stock-to-bet-on-for-economic-progress-in-the-months-ahead/
                  0
                  • Greeeeeeeaaaat news lets goooooo get back to my old comments about a week ago to know why!! Congrats my fellow holders
                    0
                    • Target is 17 guys not 10
                      0
                      • https://www.marketbeat.com/instant-alerts/nasdaq-agtc-consensus-analyst-rating-2021-03/
                        0
                        • load up if this can drop to 5. Target price is at 10.
                          0
                          • Roy Shmuelyby when?
                            0
                          • 0
                          • https://www.marketbeat.com/instant-alerts/nasdaq-agtc-consensus-analyst-rating-2021-03/
                            0
                        • my plan didn't work. so plan B is wait longer :(
                          1
                          • Bought more its going to be big soon
                            0
                            • if not secret, how many stock of AGTC holding? the reason i'm asking is , i think better to buy when it below 5 to average it. As we can see from chart it seems going to below 5.
                              0
                          • what news? Is there an FDA review due?
                            0
                            • i haven't seen in FDA schedule AGTC name.
                              1
                          • Bought 10k shares today it's going to USD 8 with upcoming news
                            0
                            • 4 USD is the true value
                              4
                              • nobody knows the true value of a stock with so much uncertainity. It can go either way. Stop posting rubbish like this
                                0
                              • true value was 3 last week now 4. do you use drug?
                                0
                            • Congrats to all who bought this under $5, and for those who are waiting, I am telling you you will never see this stock under $4 till the stock splits.
                              0
                              • 3$ by next week
                                4
                                • In your dream :) you’ll come buy it from us at $10 next week
                                  0
                              • 15 $ ...
                                1
                                • Buy the dip
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.